The FDA’s PAT (Process Analytical Technology) initiative has enabled GEA to combine its equipment design skills and process engineering know-how in order to integrate online analyzers and measurement devices into its process systems in a way which can provide real insight into the operation of the process and help customers achieve key product quality target.
Showing 4 of 9
This standalone module allows you to start developing your PAT models for a pharmaceutical continuous manufacturing process offline during the early stages of R&D.
Based on the traditional concept of a live coal-mine canary, the 21st century equivalent from GEA is a continuous real-time monitoring system that’s been designed to detect breaches in contained pharmaceutical production lines. By providing an additional level of monitoring, the Digital Canary reduces the need for routine occupational health chec...
The Lighthouse Probe® can be used for real-time monitoring of chemical and pharmaceutical processes and provides in-process window cleaning at any time, recalibration during the process, full CIP (cleaning) of wash housing and seal, and a clear view inside – even in difficult conditions.
LYOSENSE® from GEA, based on multipoint NIR measurements, provides the comprehensive and non-destructive evaluation of freeze-dried product cakes in real-time.
GEA's innovative process marks a milestone in the pretreatment of biofuels such as hydro-treated vegetable oil and sustainable aviation fuel. By eliminating the bleaching process, manufacturers benefit from significant savings potential: over 50% lower operating costs and up to 12% less CO2 emissions.
Climate change and a growing world population put increased pressure on the energy-intensive food industry to feed more people without further impacting the planet. George Shepherd, GEA’s Global Technical Sustainability Manager, explains how GEA uses its engineering know-how to help processors produce more sustainably yet increase productivity.